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Trends in Medicare Spending Near
the End of Life
Jeﬀrey Geppert and Mark McClellan
Recent decades have witnessed dramatic improvements in health at older
ages, including reductions in both mortality and morbidity. Although real
growth in health care costs has accompanied improvements in health for
the past ﬁfty years, improvements in health give hope that avoided medical
utilization due to better health may lower health care costs, or at least sig-
niﬁcantly reduce the rate of growth. In this paper, we determine the impor-
tance of changes in Medicare costs that resulted from declines in age-
speciﬁc mortality between 1988 and 1995, and describe the impact of the
mortality improvement on Medicare expenditure trends.
An umber of experts have suggested that improvements in health may
workt or educes i gniﬁcantly the burden of health care on the economy (see
Vaupel 1997, Pardes 1999, and Singer and Manton 1998). Some improve-
ments in health are likely to be the result of the innovations that avoid
costly illnesses or reduce their cost of treatment (e.g., new medical thera-
pies and pharmaceuticals that replace expensive surgical procedures).
Medical innovations may also have an indirect impact by increasing labor
productivity, reducing the relative magnitude of the health care cost bur-
den. Other studies have documented improvements in health due to non-
medical factors such as better information, behavioral improvements,
and economic developments that reduce disease morbidity (see Kennedy
1994). All else equal, all of these sources of improvements in health status
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201would be expected to reduce the intensity of health care use, leading to
lower overall health care spending.
In this paper, we present quantitative evidence on the likely importance
of improvements in health for reducing future health care costs, focusing
on changes in mortality. Perhaps the most widely cited paper on medical
spending near death is Lubitz and Riley (1993), which describes trends in
the share of Medicare program payments spent on persons aged sixty-ﬁve
and older in the last year of life from 1976 to 1988. The principal ﬁnding
of Lubitz and Riley is the large share of Medicare expenditures in the last
year of life—around 28 percent of total expenditures. A second ﬁnding is
that Medicare expenditures at the end of life decline with age.
Supporters of the view that health improvements should reduce health
care costs have emphasized these ﬁndings. If individuals are living longer
over time, then the higher costs of death are deferred. In addition, because
costs of dying are lower at older ages, death may be less costly when it
eventually occurs. Against these sources of saving are, ﬁrst, the fact that
medicalc o sts rise with age among survivors, and second, the fact that
health care costs have generally risen over time. Also, Medicare spending
might rise because of increased longevity, although the eﬀect has been
estimated as not very large (see Lubitz 1995).
Although Lubitz and Riley’s (1993) results have not previously been
applied to the problem of understanding the implications of improving
health for Medicare spending growth, they are directly relevant to consid-
ering the likely impact of improving survival on spending. They found that
the share of Medicare spending that occurred in the last year of life had
changed little during their 1976–88 study period, despite the improve-
ments in life expectancy. This constancy despite substantial mortality im-
provements suggests that other factorsm ay have been more important in
determining overall spending levels. For example, many studies have docu-
mented greater use of various intensive medical procedures on Medicare
beneﬁciaries during this time period. Alternatively, the introduction or
expansion of Medicare beneﬁts, like home health and hospice, may have
inﬂuenced utilization and costs for both survivors and decedents. In any
case, the constancy of the share spent on decedents suggests that other
factors dominated the “health eﬀect.”
We extend the Lubitz and Riley (1993) work on Medicare spending near
the end of life from 1988 to 1995, to provide direct evidence on the expen-
diture consequences of improved survival in Medicare during a longer and
more recent period. Our goal is to present empirical evidence from the
past decade on the relative importance of changes in expenditures associ-
ated with improvements in mortality, compared to changes in expenditures
given survival status, and to examine how that empirical evidence diﬀers
by gender and age.
202 Jeﬀrey Geppert and Mark McClellan6.1 Data and Methods
As in the original Lubitz and Riley (1993) article, our data come from
al ongitudinal 5 percent random sample of Medicare beneﬁciaries. Rather
than the Continuous Medicare History Sample, we calculate program pay-
ments from detailed micro-level Medicare claims data. The detailed claims
permit us to explore the use and timing of speciﬁc services, and the diag-
noses associated with them, in far more detail. Date of death was drawn
from the Health Care Financing Administration (HCFA; 2000) Medicare
Provider Analysis and Review File (MEDPAR), which in turn gets vali-
dated date-of-death information from Social Security records. Informa-
tion on Medicare programp a y m e n t sa n dt y p e so fs e r v i c ec o m ef r o m
MEDPAR and from HCFA’s (2000) the Physician/Supplier Standard Ana-
lytic File (SAF), Home Health SAF and Hospice SAF, and Outpatient
Hospital SAF.
Our sample includes only Medicare beneﬁciaries sixty-ﬁve years of age
or older. Medicare beneﬁciaries enrolled in health maintenance organiza-
tions (HMO’s) were excluded from the calculation of average program pay-
ments by type of service because some types of Medicare data are incom-
plete for HMO members. For other calculations, we included these HMO
members, because monthly Medicare payments to their health plans are
known. We report data from 1988, 1989, 1992, and 1995. The number of
persons in each sample averaged 1.6 million beneﬁciaries.
As in Lubitz and Riley (1993), we assigned annual Medicare payments
either to decedents (beneﬁciaries in the last year of life) or to survivors (all
others). Because our data include dates of service for all service types, we
assigned program payments to decedents or survivors on that basis (by
date of discharge for inpatient and skilled nursing facility care). For ex-
ample, a beneﬁciary who died in 1992 would contribute all 1992 program
payments to decedent spending in 1992. A beneﬁciary who died on 1 April
1993 would contribute 1992 program payments incurred from 1 January
1992 to 30 March 1992 and 0.33 of a person-year to survivors, and pro-
gram payments incurred after 1 April 1992 and 0.67 of a person-year to
decedents. Beneﬁciaries who did not die in 1992 or 1993 contribute 100
percent of 1992 program payments and a full person-year to survivors.
To calculate the share of Medicare program payments to decedents, we
divide the sum of program payments allocated to decedents using the
method above by total Medicare payments (in constant dollars). We repeat
the method by type of service, allocating acute inpatient, physician/sup-
plier, hospital outpatient, and nonacute care (skilled nursing facility, home
health agency, and hospice) to decedent and survivor spending to calculate
the service share. Finally, we perform the allocation of dollars and person-
yearss eparately by age group. To calculate the average program payments
Trends in Medicare Spending Near the End of Life 203ford ecedents (and survivors) by age group, we divide the sum of payments
allocated to descendent (survivor) spending by the sum of decedent (survi-
vor) person-year weights. The results reported in the tables are in constant
dollars. To perform the decomposition described below, the age-speciﬁc
average program payments for survivors and decedents are ﬁrst inﬂated to
1995 dollars using the overall CPI.
We summarize the quantitative contribution of changes in mortality and
changes in intensity to medical spending through a ﬁrst-order decomposi-
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where j denotes a particular health status group. The decomposition is
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The ﬁrst component of the change is the “mortality eﬀect,” or the change
in per capita spending that results only from the change in the rate at
which the elderly die at each age, holding program payments (and demo-
graphics) constant. The second component is the “utilization eﬀect,” or
the change in per capita spending that results only from the change in
program payments given survival status (i.e., decedent or survivor), hold-
ing mortality (and demographics) constant. This decomposition of per
capita growth does not reﬂect the growth in total Medicare spending due
to the increased number of elderly, which we label the “demographic ef-
fect.” The demographic eﬀectc a ptures the consequences for program ex-
penditures of changes in the number of elderly in each age and gender
segment of the population.
Theu t ilization eﬀecti sthe result of changes in utilization of particular
services,a nd also of changes in the prices of those services. Because Medi-
204 Jeﬀrey Geppert and Mark McClellancare regulates service prices and has held price increases below the rate
of inﬂation, growth in Medicare expenditures generally results from the
provision of more or more-intensive covered services, and from changes in
billing practices (e.g., upcoding).
6.2 Results
Figure 6.1 summarizes real expenditure growth rates by survival status,
including a comparison to the earlier period studied by Lubitz and Riley
(1993), and an even earlier period based on work by Piro and Lutins
(1974). Over the past thirty years, the average annual percentage change
in Medicare programp a yments has been high (3–7 percent per year) and
relatively constant between survivors and decedents. In the earliest time
period, between 1967 and 1976, real expenditure growth rates were slightly
higher for decedents than survivors. In the time period between 1976 and
1988, real expenditure growth rates were the same for decedents and survi-
vors and constant across ages. In more recent years, the growth rate for
survivors has exceeded the growth rate for decedents, especially at older
ages.T he growth rate and pattern is largely the same for males and females
from 1988 to 1995, with the overall growth rate for males slightly less than
forf e males. The acceleration in spending growth for survivors at older
ages is slightly greater for females than for males.
Figure 6.2 summarizes real acute and nonacute spending growth rates
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Fig. 6.1 Average annual percentage real change in Medicare payments per person-
year, according to survival status and age, 1967–76, 1976–88, and 1988–95for the 1988–95 period. Nonacute care is deﬁned to include skilled nursing
facility (nonacute hospital) stays, home health care, and hospice care.
These services areg e nerally of lower intensity and are supportive in na-
ture. Acute care includes services that are likely to be for acute illnesses,
including acute hospitalizations, outpatient visits, and physician services.
Many of these services are probably related to ongoing care or treatment
forc omplications of chronic conditions. Nonetheless, in contrast to the
nonacute services, these treatments consist primarily of medical interven-
tionsi ntended to alter the course of an illness, and not of supportive care.
Such interventions are also provided in nonacute settings, but a much
larger proportion of nonacute service use consists of supportive care for
beneﬁciaries with chronic impairments. The ﬁgure shows that acute-care
spending, which has historically been the bulk of Medicare expenditures,
has increased at virtually identical rates for survivors and decedents,
around 2–3 percent per year. Growth forn o nacute services has been far
more rapid since 1988, averaging well over 15 percent per year for both
survivors and decedents. In contrast to a minimal relationship to age for
decedents, the rate of nonacute spending growth for survivors was higher
with increasing age, presumably reﬂecting the higher rates of chronic ill-
ness and disability among older survivors. As we describe in more detail
below, nonacute spending growth has accounted for most of the spending
growth in the past decade for decedents, and especially for survivors.
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Fig. 6.2 Average annual percentage real change in Medicare payments per person-
year, according to survival status and age, 1988–95Figure 6.3 shows the per-person change in Medicare spending resulting
from mortality declines from 1988 to 1995, holding payments and demo-
graphics at 1988 levels. This ﬁgure isolates the contribution of changes in
age-speciﬁc mortality rates to spending growth over the period. The left
side of the ﬁgure (decedents) shows the per capita cost reduction from
averting the higher costs of dying. The right side of the ﬁgure (survivors)
shows the per capita cost increases from the greater number of survivors.
Because we are focusing on current-year Medicare costs, we do not show
the higher costs of survivors in future years in this ﬁgure. The net expendi-
ture impact on current-year costs, the diﬀerence between the decedent and
survivor eﬀects, depends on both the change in mortality and the diﬀer-
ence in expenditures between survivors and decedents in the demographic
group. The expenditure impact of mortality rate declines was greatest for
the seventy-ﬁve to seventy-nine age group (which has intermediate mortal-
ity rates and spending diﬀerences), resulting in a $74 per person decline
in payments. The overall decline in per-person payments was $51. Thus,
mortality improvements did inﬂuence spending growth, but the magnitude
of the eﬀect was modest.
Figure 6.4 shows that the expenditure impact of mortality-rate declines
was larger for males, and more variable across age groups, with an overall
decline in per-person payments of $88 (including a $147 per person decline
for the seventy-ﬁve to seventy-nine age group). The per capita cost in-
creases from the greater number of male survivors was also higher for the
seventy-ﬁve to seventy-nine age group, but still small in magnitude. Figure
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Fig. 6.3 Per-person change in expenditures: 1988 payments  Change in
Mortality, 1988–956.5 shows that, for females, the expenditure impact of mortality rate de-
clines was considerably smaller, less than $30 per person. In contrast to
males, the impact was greatest for the oldest females, those aged eighty-
ﬁve and up, with a per-person decline in payments of $52. These diﬀer-
encesw ere primarily the result of a weaker relationship between age and
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Fig. 6.4 Per-male change in expenditures: 1988 Payments  Change in
Mortality, 1988–95
Fig. 6.5 Per-female change in expenditures: 1988 Payments  Change in
Mortality, 1988–95the diﬀerence in expenditures between decedents and survivors than for
males; thus, the larger absolute mortality gains at older ages were relatively
more important.
Figure 6.6 shows the per-person change in Medicare spending resulting
from changes in expenditures per beneﬁciary, holding age-speciﬁc mortal-
ityr ates (and demographics) at 1988 levels. This ﬁgure isolates the contri-
bution to spending growth of changes in expenditures within survival
groups. It is obvious from the ﬁgure that these changes dwarf the reduc-
tionsi ne xpenditures from lower mortality over time. Not only does the
growth in per capita expenditures due to higher spending on decedents far
exceed the savings from reduced mortality, but the eﬀect ofs p e n ding
growth for survivors on per capita expenditures was signiﬁcantly greater
than that for decedents. Even though the absolute spending increases were
lower, survivors comprise the bulk of Medicare spending because they
comprise the vast majority of Medicare beneﬁciaries. In contrast to the
mortality eﬀects described above, the magnitude of the utilization eﬀect
increases with age for both survivors and decedents. Figures 6.7 and 6.8
show that similar patterns hold for both males and females, with a slightly
larger utilization eﬀectf or females at older ages.
Table 6.1 summarizes the decomposition of expenditure growth de-
scribed in the preceding ﬁgures. The mortality eﬀect is the share of per-
person expenditure growth explained by the reduction in age-speciﬁc mor-
tality, and the utilization eﬀect is the share explained by the increase in
expenditures given survival status. These are both ﬁrst-order approxima-
tions, but as the interaction eﬀect shows, the approximation is close. The
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Fig. 6.6 Per-person change in expenditures: 1988–95 Change in Payments 
1988 Mortalitymortality eﬀecti sasmall contributor to overall expenditure growth: Com-
paredt oobserved expenditure growth, the analysis suggests that Medicare
expenditures per beneﬁciary would have grown by about 4 percent more
over the 1988–95 period if no mortality improvement had occurred. The
mortality eﬀecti sl arger for males than females. For males, Medicare ex-
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Fig. 6.7 Per-male change in expenditures: 1988–95 Change in Payments 
1988 Mortality
Fig. 6.8 Per-female change in expenditures: 1988–95 Change in Payments 
1988 Mortalitypenditures per beneﬁciary would have grown by about 9.6 percent more if
no mortality improvements had occurred. The percentage is even larger
for middle-range elderly males (aged seventy to seventy-four and seventy-
four to seventy-nine) nearly 15 percent. For females, expenditures per ben-
eﬁciary would have grown only 2.3 percent more, and that percentage re-
mains the same over all female age groups. This suggests that for one dem-
ographic group, namely males aged seventy to seventy-four and seventy-
four to seventy-nine, the mortality eﬀectdid have some impact on expendi-
ture growth, although the utilization eﬀect was still eight times greater.
Overall, the mortality eﬀect had onlyam o d e st impact on per-beneﬁciary
expenditure growth because the utilization eﬀect was large in comparison,
more than twenty times greater.
Table 6.2 describes the contributing factors to the large utilization eﬀect
in more detail. The table shows that utilization increases for survivors ac-
counted for around 73 percent of utilization growth—virtually identical
to their share of base-year spending, again indicating that utilization ef-
fects are large for survivors as well as decedents. Table 6.2 also shows that
nonacute spending for both survivors and decedents accounted for just
over half of theutilization eﬀect. This may seem likea relatively small share
given the enormous diﬀerences in growth rates, but it is a reﬂection of the
fact that nonacute spendingr epresented only a small share of Medicare
costs at the beginning of the study period. This is a marked change from
the earlier history of Medicare spending growth. For the 1976–88 analysis
by Lubitz and Riley, nonacute spending growth likely accounted for virtu-
ally all of the utilization eﬀect. Moreover, the importance of nonacute care
Table 6.1 Percent Explained by the Mortality Eﬀect versus the Utilization Eﬀect
Gender and Per Person Demographic Mortality Utilization Interaction
Age Groups ($) Eﬀect (%) Eﬀect (%) Eﬀect (%) Eﬀect (%)
Overall 1,135 10.2 4.5 105.5 1.0
Males
Overall 922 10.6 9.6 111.4 1.8
65–69 665 1.5 7.9 110.2 2.2
70–74 660 14.2 15.1 117.2 2.1
75–79 1,022 13.4 14.4 116.9 2.5
80–84 1,604 21.0 6.8 108.1 1.3
85 2,163 21.2 1.4 101.7 0.3
Females
Overall 1,269 9.9 2.3 102.9 0.6
65–69 746 0.0 2.2 102.9 0.7
70–74 990 12.4 2.6 103.3 0.7
75–79 1,397 9.8 2.5 103.2 0.6
80–84 1,924 16.8 2.1 102.6 0.6
85 2,303 22.7 2.2 102.6 0.3
Trends in Medicare Spending Near the End of Life 211in the utilization eﬀectw as highly age and sex dependent: For elderly
males, nonacute care accounted for 45 percent of the utilization eﬀect; for
sixty-ﬁve-to sixty-nine-year-old males, nonacute care accounted for less
than one-third of the total utilization eﬀect; for sixty-ﬁve-to sixty-nine-
year-oldf e males, a little over one-third; and for beneﬁciaries aged eighty-
ﬁve and older, it accounted for over two-thirds of the eﬀect. For all ages,
nonacute care was a somewhat more important contributor to the utiliza-
tion eﬀectf or females than for males.
6.3 Discussion
Our analysis of recent trends in Medicare spending near the end of life
has three major conclusions. First, the rate of spending growth was similar
for survivors and decedents—actually slightly larger for the oldest female
survivors than for other demographic groups, as a result of relatively more
rapid growth in spending for nonacute services. Thus, spending growth for
survivors continues to account for most of the growth in Medicare costs.
This seems to reﬂect a modest but important long-term trend. For Medi-
care’s ﬁrst decade, the rate of spending growth was slightly higher for dece-
dents than survivors; and between the late 1970s and late 1980s, the growth
rate was similar for the two groups.
Second, in recent years growth in spending for nonacute services has
accounted for half of overall spending growth. Thus, spending growth for
Table 6.2 Contributing Factors to Utilization Eﬀect
Acute-Care Utilization Nonacute-Care Utilization
Gender and Decedents Survivors Decedents Survivors
Age Groups (%) (%) (%) (%)
Overall 12.39 36.03 14.72 36.86
Males
Overall 16.17 38.56 16.98 28.29
65–69 18.68 53.12 9.09 19.09
70–74 16.11 43.13 13.90 26.80
75–79 16.95 38.83 16.76 27.51
80–84 14.60 27.84 21.62 36.04
85 12.16 16.52 31.63 39.60
Females
Overall 10.10 34.27 13.33 42.28
65–69 10.84 54.00 7.49 27.69
70–74 11.70 42.36 9.79 36.12
75–79 10.15 32.41 12.58 44.81
80–84 9.56 27.99 14.25 48.21
85 8.34 16.92 21.92 52.78
212 Jeﬀrey Geppert and Mark McClellandecedents was not primarily the result of increasing heroic, intensive mea-
sures near the end of life. In addition, although greater coverage of non-
acute alternatives might be expected to aﬀecte n d-of-life costs dispropor-
tionately, growth rates for nonacute services were even greater for older
survivors than decedents. Large utilization eﬀects for both acute and non-
acute services occurred in both groups.
Third, although improvements in mortality have helped limit Medicare
spending growth over time, this eﬀect has been swamped by the much
larger increases in expenditures given survival status for decedents and
survivors alike. Without the survival improvements, our estimates suggest
that total Medicare spending per beneﬁciary would have grown only 4
percent more than it did. Improvements in mortality were relatively more
important in limiting spending growth for males than for females, and for
mid-elderly males especially, but still much smaller than the larger in-
creases in expenditures given survival status. Thus, we conclude that in-
creasing utilization for both survivors and decedents has been a far more
important determinant of Medicare spending over time than have im-
provements in mortality. If anything, the slightly more rapid recent growth
in spending in some survivor groups—due to the increasing importance
of nonacute care—suggests that survival improvements have probably be-
come even more marginal contributors to explaining trends in spending.
This is not to say that the growth in Medicare spending has been waste-
ful. Life expectancy for an average elderly Medicare beneﬁciary increased
by 4.9 months between 1988 and 1995, at a total cost to Medicare of
$1,135—that is, around $2,780 per additional life-year. If an additional
life-year were valued at only $25,000, the increased Medicare spending
would be worthwhile if it accounted for only 11 percent of the observed
improvement in mortality. Moreover, as we noted above, much of the
spending growth occurred in chronic, supportive-care services that would
be expected to improve quality of life as well as its length. Thus, although
improvements in health have probably oﬀsetaminiscule share of the
growth in medical spending over the past decade, it does not imply that
such spending growth is excessive. However, it does imply that, unless the
future is fundamentally diﬀerent, improving mortality may not have a very
noticeablei mpact on medical spending growth.
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Comment David M. Cutler
Geppert and McClellan present an interesting analysis of the roles of mor-
tality change and intensity change in explaining the growth of Medicare
costs. End-of-life spending is a substantial component of Medicare costs;
those in the last year of life use six times more Medicare services than
those not in the last year of life. Furthermore, people who die at later ages
consume fewer Medicare services at the end of life than those who die at
younger ages. The combination of these two factors means that as mortal-
ityr ates fall and deaths occur at later ages, Medicare spending should fall.
Geppert and McClellan argue that this view is right but quantitatively
small. Much more important is the fact that costs have increased for every-
one—those near and farther away from death. This “intrinsic cost growth”
has driven the Medicare system in the past, they argue, and will continue
to do so in the future.
Geppert and McClellan reach a conclusion similar to that of my own
work (Cutler and Meara chap. 7 in this volume, and Cutler and Sheiner
1999). In all three papers, technological change is the beast in the system:
rapid growth of technology, high Medicare costs; slow growth of technol-
ogy, lower costs. I am more or less in agreement with all that Geppert and
McClellan say.
My one hesitation is that Geppert and McClellan look only at mortality,
nota to verall health. In addition to living longer, people are healthier.
Since healthier people spend less than sicker people, the improvement in
health is another form of cost saving. For example, those with ﬁve or more
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David M. Cutler is professor of economics at Harvard University and a research associate
of the National Bureau of Economic Research.activities of daily living (ADL) impairments (inability to perform basic
tasks such as bathing, cleaning, etc.) spend perhaps $7,000 per year in
Medicare, whereas those with no disability might spend $1,000 to $2,000.
As disability rates fall, average spending will fall as well.
To evaluate the magnitude of this, Manton, Corder, and Stallard (1997)
show that disability rates among the elderly are falling by 1 to 1.5 percent
pery ear. Over the decade which Geppert and McClellan examine this
would reduce average disability rates by 10 to 15 percent. The implied re-
duction in spending is about 5 to 10 percent. This is of moderate size.
Indeed, looking forward, improvements in health may play a more im-
portant role in forecasting medical costs than they did in the past. Table
6C.1 shows forecasts of medical spending on the elderly between 1992 and
2050, taken from Cutler and Sheiner (1999). The ﬁrst row uses standard
projections for Medicare projections. Medicare costs vary by age and sex,
butn ot by health status. For clarity, age- and sex-speciﬁc costs are as-
sumed to be constant over time, so only changes in the age and sex distri-
bution of the population aﬀects spending. The increased share of the older
population is projected to raise spending by 9 percent over the next half-
century.
The next row shows the eﬀecto fi mproved health—both reduced mor-
bidity andreducedmortality.Comparedtotheprojectionwithoutaccount-
ing for better health, the diﬀerence in 2050 is 18 percent (from a 9 percent
increase toa9p e r c e n td e c r e a s e ) .T h echange is substantial.
The third row shows the impact of intrinsic cost growth at the same rate
relative to gross domestic product as the past half-century. If costs con-
tinuet or ise at this rate, per-person spending will increase by 500 percent
in the next half-century. Clearly, these intrinsic increases dominate the
Medicare future. Demographics are much less important.
However, the link between demographics and intrinsic growth may be
more subtle. On the one hand, health changes may be driven by increased
spending, so that spending increases in the future might have even larger
eﬀects on the health of the elderly. On the other hand, demographic change
may aﬀect the rate of intrinsic cost growth. As people become healthier,
will spending growth rise, as more-healthy people receive intensive treat-
ments? Or will spending growth fall as we learnh ow to prevent disease
Table 6C.1 Forecasts of Medicare Spending
1992 2010 2030 2050
Age and sex only 1.00 1.03 1.01 1.09
Age, sex, and improved health 1.00 0.97 0.90 0.91
Age, sex, improved health, and intrinsic
cost growth 1.00 1.59 3.59 6.12
Source: Cutler and Sheiner (1999).
Trends in Medicare Spending Near the End of Life 215more cheaply? These are the important questions that research needs to
address. Geppert and McClellan’s paper, along with other work on this
topic, has provided an important start.
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